TIDMAGY

RNS Number : 1689G

Allergy Therapeutics PLC

18 November 2015

18 November 2015

Allergy Therapeutics plc

("Allergy Therapeutics" or the 'Company")

Result of Annual General Meeting

Allergy Therapeutics, the fully integrated specialty pharmaceutical company specialising in allergy vaccines, announces that at the Annual General Meeting held today, all the resolutions put to that meeting were duly passed.

For further information:

 
 Allergy Therapeutics                                +44 (0) 1903 845 820 
 Manuel Llobet, Chief Executive Officer 
 Ian Postlethwaite, Finance Director 
 
 Panmure Gordon                                      +44 (0) 20 7886 2500 
 Freddy Crossley / Peter Steel / Duncan Monteith, 
  Corporate Finance 
 Tom Salvesen, Corporate Broking 
 
 FTI Consulting                                      +44 (0) 20 3727 1000 
 Simon Conway / Mo Noonan / Victoria Foster 
  Mitchell 
 

Note to editors:

About Allergy Therapeutics

Allergy Therapeutics is a specialty pharmaceutical company focused on allergy vaccination. It has a growing business achieving revenue in the last financial year of GBP43 million mainly in Europe through its own sales and marketing infrastructure and further afield through distributors.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGFFEFEAFISEEF

(END) Dow Jones Newswires

November 18, 2015 07:23 ET (12:23 GMT)

Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Allergy Therapeutics Charts.
Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Allergy Therapeutics Charts.